SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-161727
Filing Date
2018-05-14
Accepted
2018-05-14 09:16:41
Documents
61
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d698506d10q.htm 10-Q 732140
2 EX-10.1 d698506dex101.htm EX-10.1 35879
3 EX-10.2 d698506dex102.htm EX-10.2 67792
4 EX-31.1 d698506dex311.htm EX-31.1 7691
5 EX-31.2 d698506dex312.htm EX-31.2 7598
6 EX-32.1 d698506dex321.htm EX-32.1 5697
  Complete submission text file 0001193125-18-161727.txt   3780455

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT snna-20180331.xml EX-101.INS 498621
8 XBRL TAXONOMY EXTENSION SCHEMA snna-20180331.xsd EX-101.SCH 43920
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snna-20180331_cal.xml EX-101.CAL 43493
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snna-20180331_def.xml EX-101.DEF 177281
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE snna-20180331_lab.xml EX-101.LAB 400700
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snna-20180331_pre.xml EX-101.PRE 288898
Mailing Address 30699 RUSSELL RANCH ROAD, SUITE 140 WESTLAKE VILLAGE CA 91362
Business Address 30699 RUSSELL RANCH ROAD, SUITE 140 WESTLAKE VILLAGE CA 91362 (818) 629-2256
Sienna Biopharmaceuticals, Inc. (Filer) CIK: 0001656328 (see all company filings)

IRS No.: 273364627 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-38155 | Film No.: 18828908
SIC: 2834 Pharmaceutical Preparations